Teladoc, Inc. (NYSE:TDOC) Insider Sells $1,663,681.52 in Stock

Teladoc, Inc. (NYSE:TDOC) insider Adam C. Vandervoort sold 53,806 shares of the firm’s stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $30.92, for a total value of $1,663,681.52. Following the completion of the transaction, the insider now owns 33,008 shares of the company’s stock, valued at $1,020,607.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Teladoc, Inc. (TDOC) traded down 2.16% during mid-day trading on Friday, reaching $29.50. The company had a trading volume of 485,628 shares. The stock’s market capitalization is $1.67 billion. The company’s 50-day moving average is $33.13 and its 200-day moving average is $27.90. Teladoc, Inc. has a one year low of $14.00 and a one year high of $36.90.

Teladoc (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, August 2nd. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.26) by $0.02. Teladoc had a negative net margin of 47.75% and a negative return on equity of 19.88%. The firm had revenue of $44.60 million for the quarter, compared to the consensus estimate of $44.39 million. During the same period last year, the company posted ($0.38) earnings per share. Teladoc’s revenue for the quarter was up 68.3% on a year-over-year basis. Equities research analysts anticipate that Teladoc, Inc. will post ($1.44) earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Teladoc, Inc. (NYSE:TDOC) Insider Sells $1,663,681.52 in Stock” was published by BNB Daily and is the property of of BNB Daily. If you are viewing this story on another domain, it was stolen and republished in violation of United States and international copyright law. The original version of this story can be accessed at https://www.baseball-news-blog.com/2017/08/20/teladoc-inc-nysetdoc-insider-adam-c-vandervoort-sells-53806-shares-updated.html.

TDOC has been the subject of a number of analyst reports. Zacks Investment Research downgraded Teladoc from a “hold” rating to a “sell” rating in a research note on Tuesday, May 2nd. Chardan Capital raised their price target on Teladoc from $28.00 to $30.00 and gave the company a “buy” rating in a research note on Tuesday, May 9th. Robert W. Baird restated a “buy” rating and issued a $28.00 price target on shares of Teladoc in a research note on Tuesday, May 9th. Craig Hallum downgraded Teladoc from a “buy” rating to a “hold” rating and raised their price target for the company from $28.00 to $32.00 in a research note on Friday, May 12th. Finally, KeyCorp assumed coverage on Teladoc in a research report on Wednesday, May 17th. They issued an “overweight” rating and a $37.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and ten have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $35.55.

Large investors have recently bought and sold shares of the company. US Bancorp DE increased its stake in Teladoc by 10.3% in the first quarter. US Bancorp DE now owns 4,617 shares of the health services provider’s stock valued at $116,000 after buying an additional 433 shares in the last quarter. Jaffetilchin Investment Partners LLC increased its stake in Teladoc by 1.8% in the first quarter. Jaffetilchin Investment Partners LLC now owns 45,225 shares of the health services provider’s stock valued at $1,131,000 after buying an additional 814 shares in the last quarter. Teachers Advisors LLC increased its stake in Teladoc by 5.3% in the fourth quarter. Teachers Advisors LLC now owns 35,205 shares of the health services provider’s stock valued at $581,000 after buying an additional 1,759 shares in the last quarter. Rosenblum Silverman Sutton S F Inc. CA increased its stake in Teladoc by 2.7% in the second quarter. Rosenblum Silverman Sutton S F Inc. CA now owns 67,395 shares of the health services provider’s stock valued at $2,339,000 after buying an additional 1,800 shares in the last quarter. Finally, Bank of Montreal Can increased its stake in Teladoc by 214.2% in the second quarter. Bank of Montreal Can now owns 3,516 shares of the health services provider’s stock valued at $123,000 after buying an additional 2,397 shares in the last quarter. Hedge funds and other institutional investors own 94.51% of the company’s stock.

About Teladoc

Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

Insider Buying and Selling by Quarter for Teladoc (NYSE:TDOC)

Receive News & Ratings for Teladoc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply